Koen De Geest
- Reproductive Medicine top 0.5%
- Oncology top 5%
- Obstetrics and Gynecology top 1%
- Surgery top 10%
- Molecular Biology
- Co-authors
- Anil K. SoodSusan K. LutgendorfJeffrey M. FowlerWilliam P. McGuirePeter HarperMark F. BradyMichael FriedländerLawrence M. Roth
- Topics
- Ovarian cancer diagnosis and treatment (15 papers)Endometrial and Cervical Cancer Treatments (11 papers)Colorectal and Anal Carcinomas (6 papers)
- Partner nations
- United StatesAustraliaBelgium
In The Last Decade
Koen De Geest
40 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Reproductive Medicine 878
- Oncology 693
- Obstetrics and Gynecology 618
- Surgery 495
- Molecular Biology 458
Countries citing papers authored by Koen De Geest
This map shows the geographic impact of Koen De Geest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koen De Geest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koen De Geest more than expected).
Fields of papers citing papers by Koen De Geest
This network shows the impact of papers produced by Koen De Geest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koen De Geest. The network helps show where Koen De Geest may publish in the future.
Co-authorship network of co-authors of Koen De Geest
This figure shows the co-authorship network connecting the top 25 collaborators of Koen De Geest. A scholar is included among the top collaborators of Koen De Geest based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koen De Geest. Koen De Geest is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 41 | |
| 2 | 54 | |
| 3 | 24 | |
| 4 | 42 | |
| 5 | 10 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 46 | |
| 9 | GOG 175: A Randomized phase III trial of IV carboplatin (AUC 6) and paclitaxel 175 mg/m(2) Q 21 days x 3 courses plus low-dose paclitaxel 40 mg/m(2)/wk versus IV carboplatin (AUC 6) and paclitaxel 175 mg/m(2) Q 21 days x 3 courses plus observation in patients with early-stage ovarian carcinoma | 0 |
| 10 | 13 | |
| 11 | 30 | |
| 12 | 126 | |
| 13 | Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroupbreakdown → | 500 |
| 14 | 195 | |
| 15 | 44 | |
| 16 | 27 | |
| 17 | 19 | |
| 18 | 27 | |
| 19 | 28 | |
| 20 | 2 |
About Koen De Geest
Koen De Geest is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology, having authored 44 papers that have together received 2.3k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (15 papers), Endometrial and Cervical Cancer Treatments (11 papers) and Colorectal and Anal Carcinomas (6 papers). The work is most often cited by research in Reproductive Medicine (878 citations), Obstetrics and Gynecology (618 citations) and Oncology (693 citations). Koen De Geest has collaborated with scholars based in United States, Australia and Belgium. Frequent co-authors include Anil K. Sood, Susan K. Lutgendorf, Jeffrey M. Fowler, William P. McGuire, Peter Harper, Mark F. Brady, Michael Friedländer, Lawrence M. Roth, Michael A. Bookman and Peter A. Argenta. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.